India Puts Sun Pharma Clinical Research Work On Hold At Suspect Lab
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical has been ordered to suspend its clinical research work at a Mumbai laboratory on grounds it does have regulatory approval for the facility.